Unstable angina non ST elevation myocardial infarction biomarkers

Cardiology Network
Discuss Unstable angina non ST elevation myocardial infarction biomarkers further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Template:WikiDoc Cardiology News Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Cardiac biomarkers

If there is an elevation of a marker of myocardial necrosis (CK-MB or troponin), then the patient does not have unstable angina, but instead has a syndrome of either ST elevation MI or Non ST elevation MI depending upon the electrocardiogram changes.

The traditional definitions of MI were revisited in 2000 in a consensus document of a joint committee of the European Society of Cardiology(ESC) and American College of Cardiology(ACC). In this definition, myocardial necrosis is defined by an elevation of troponin above the 99th percentile of normal. Biomarkers currently used to detect ischemia are Creatine kinase-MB and Troponins. Other biomarkers like aspartate transaminase and lactate dehydrogenase which were earlier used should be avoided.

Creatine kinase-MB

It is a cytosolic carrier protein for highenergy phosphates, has long been the standard marker for the diagnosis of MI. However, it is less sensitive and less specific for MI than cardiac troponins. However, it is useful in special clinical situations one of which is the diagnosis of early infarct extension (reinfarction), because the short half-life of CK-MB compared with troponin permits the detection of a diagnostic new increase after initial peak. Another situation is the diagnosis of a periprocedural MI, because the diagnostic and prognostic value of CK-MB in these situations has been extensively validated.

Cardiac Troponins

Cardiac troponin provides highly sensitive and specific result in detecting cell necrosis. There are 3 types of tropnins- Troponin T(cTnT), troponin I(cTnI) and troponin C(cTnC). Cardiac troponins refers specifically to either TnT or TnI. Because cTnT and cTnI generally are not detected in the blood of healthy persons, the cutoff value for elevated cTnT and cTnI levels may be set to slightly above the upper limit of the performance characteristics of the assay for a normal healthy population. Therefore, physicians need to know the sensitivity and the cut off of the test used in their hospital.